In a strangely structured deal, AstraZeneca has nationwide licensed Junshi Biosciences' PD-1 inhibitor for only one indication in China. Takeda continued to sell...
On the occasion of "World Hypertension Day" the government of Punjab launched the awareness campaign to raise awareness among high risk populations about the...